Cerenome is trading at $2.86, down -6.23%, with no company-specific announcement identified for August 31, 2026.
- The latest investor-relations release is dated August 20, 2026.
- CNBC reports there is no recent news for the company.
- Broader markets are modestly lower amid geopolitical and interest-rate concerns, but available evidence does not establish a direct cause for Cerenome’s decline.